goal_code	goal_labelEN	goal_descEN	target_code	target_descEN	indicator_code	indicator_reference	indicator_descEN	series_release	series_tags	series	seriesDescription	geoAreaCode	geoAreaName	level	parentCode	parentName	type	X	Y	ISO3	UN_Member	Country_Profile	timeCoverage	geoInfoUrl	years	min_year	max_year	n_years	unitsCode	unitsDesc	reportingTypeCode	reportingTypeDesc	value_2000	value_2001	value_2002	value_2003	value_2004	value_2005	value_2006	value_2007	value_2008	value_2009	value_2010	value_2011	value_2012	value_2013	value_2014	value_2015	value_2016	value_2017	latest_value	basePeriod	valueDetails	footnotes	sources	timeDetails	nature
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	104	Myanmar	4	35	South-Eastern Asia	Country	96.51752295	21.19332882	MMR	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	7.867655	8.463546	8.291086	16.051407	9.79831	13.134812	13.989862	24.594806	33.24711	47.274045	60.755541	38.368766	93.404899	115.12228	145.003099	95.101226	148.882316	118.430567	118.430567			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	108	Burundi	5	14	Eastern Africa	Country	29.89080992	-3.366387428	BDI	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	3.555035	3.172104	3.463798	5.589661	8.455633	14.807126	14.868508	23.762365	36.324878	28.177362	47.866099	43.778409	37.984538	51.431366	43.294374	50.847848	103.300895	95.035905	95.035905			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	11	Western Africa	4	202	Sub-Saharan Africa	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	136.703111	252.320312	162.603939	205.040849	314.133649	327.492797	455.292134	484.132755	676.016179	1014.951094	913.561324	836.872992	1047.945946	1282.693945	1443.923276	1928.487372	1657.509974	1703.94552	1703.94552			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	112	Belarus	4	151	Eastern Europe	Country	28.04940161	53.54193075	BLR	1	1			[2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2005	2017	13	CON_USD	Constant USD	G	Global						1.033547	1.058457	2.602181	5.398656	1.023604	9.727176	5.121491	6.144231	5.409029	5.48672	1.263877	5.841114	3.044696	3.044696			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	116	Cambodia	4	35	South-Eastern Asia	Country	104.922836	12.71163737	KHM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	18.347986	24.406794	11.290689	22.955425	13.577868	43.649534	39.80319	48.826627	45.821076	59.003229	100.658651	52.162675	53.935823	65.112063	62.611857	72.247159	48.362405	77.321894	77.321894			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	12	Algeria	4	15	Northern Africa	Country	2.678164227	28.15940032	DZA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.567221	1.280171	0.705574	0.525336	0.475827	0.638615	0.40542	1.835487	0.288487	0.322814	1.500692	2.719072	0.461594	0.274649	0.164685	0.305488	0.732258	0.42204	0.42204			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	120	Cameroon	5	17	Middle Africa	Country	12.7419827	5.692387031	CMR	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	22.684657	3.971681	6.457181	8.371229	19.790093	23.717039	27.704864	22.055082	24.481995	33.689427	23.943741	91.670297	40.652342	67.625684	68.218837	96.684175	53.234911	59.189624	59.189624			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	127	Southern Asia (excluding India)	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	150.679888	144.611338	110.290847	129.446219	190.059744	310.687369	454.081669	520.733457	554.691857	618.08032	753.083799	496.003057	645.665168	885.83405	693.303531	743.785889	830.306007	929.954916	929.954916			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	13	Central America	4	419	Latin America and the Caribbean	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	37.830725	48.342777	44.31998	50.19595	47.144216	80.417041	88.8302	100.115714	99.02907	85.467012	82.715735	77.789234	84.314828	74.725807	81.423825	115.467522	83.141838	84.270436	84.270436			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	132	Cabo Verde	5	11	Western Africa	Country	-23.63544151	15.07791834	CPV	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.239573	4.20167	0.313623	0.218792	1.51941	0.939003	0.445567	0.1475	0.29997	0.571343	1.473652	3.136727	5.299414	3.19638	1.720393	2.552994	0.50827	1.635125	1.635125			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	135	Caucasus and Central Asia	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	41.139244	37.040679	51.07942	47.597228	58.617267	58.559986	66.218948	86.483846	91.172124	100.720465	132.658044	126.630358	114.272888	105.248382	118.15201	91.228273	146.645937	138.803005	138.803005			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	14	Eastern Africa	4	202	Sub-Saharan Africa	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	407.163261	414.618727	342.536305	421.26476	456.321903	559.314857	752.27165	884.936211	968.822095	1135.568319	1284.83182	1488.761139	1857.99148	2292.183181	1974.805835	2226.268291	1861.645842	2564.272608	2564.272608			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	140	Central African Republic	5	17	Middle Africa	Country	20.93559492	7.003720791	CAF	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	1.246098	6.639056	8.100197	3.667506	11.392566	8.386797	7.398917	5.999813	11.032561	5.952631	9.384185	9.194774	15.411803	19.408525	36.599655	23.516331	0.466638	48.872532	48.872532			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	142	Asia	2	1	World	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	837.127254	517.168677	652.445705	670.537308	784.083814	1558.178556	1668.386279	1646.283855	1478.383796	1635.585419	2054.512161	1613.621834	1896.26712	2252.971411	1920.555566	2117.729244	2376.007064	3065.20668	3065.20668			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	143	Central Asia	3	142	Asia	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	20.772062	26.485818	40.152049	39.910548	52.72084	42.52081	47.414975	48.745017	61.738539	69.733319	91.613942	85.745327	95.013854	76.985396	97.545693	76.286138	118.850769	116.227491	116.227491			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	144	Sri Lanka	4	34	Southern Asia	Country	80.70489654	7.614693343	LKA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	6.106443	14.896581	2.794798	6.738648	10.339747	11.170732	10.270316	11.549679	17.4546	20.009924	29.977973	15.643856	20.227435	17.550155	22.615928	34.222669	20.683697	49.015753	49.015753			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	145	Western Asia	3	142	Asia	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	95.539948	40.886872	53.235086	89.497123	155.40756	643.82899	545.676267	391.189128	234.672411	254.431833	271.086669	211.06519	211.080143	235.351718	282.514074	274.132665	309.257322	747.82965	747.82965			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	148	Chad	5	17	Middle Africa	Country	18.66618401	15.36279341	TCD	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	30.396883	4.201797	7.211121	7.276834	13.211564	12.82458	7.651029	11.341099	14.745716	14.947641	40.221483	20.214403	25.479693	59.295579	43.192655	22.730432	61.338405	36.323217	36.323217			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	15	Northern Africa	3	2	Africa	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	63.1694	51.06968	63.331144	36.526207	56.821168	114.232029	102.072449	156.826474	177.543993	113.31831	163.667773	122.744658	131.883254	137.855586	107.436066	133.671442	224.26233	122.970311	122.970311			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	150	Europe	2	1	World	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	43.508498	30.94739	18.61471	25.10495	17.363701	41.292194	58.700846	51.91379	51.534139	35.748148	47.573162	63.371789	62.579886	60.930125	64.461943	74.51142	127.0765	112.574384	112.574384			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	151	Eastern Europe	3	150	Europe	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	10.12241	1.303986	1.289975	1.035606	1.806856	12.144322	18.824346	20.424329	28.055429	27.398302	31.27967	47.903617	51.458083	50.014561	49.02318	64.720387	86.333104	49.854671	49.854671			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	152	Chile	5	5	South America	Country	-71.23029019	-35.2652885	CHL	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.106602	0.087758	0.314027	0.217185	1.904342	2.221732	0.543584	0.282488	0.289419	0.60515	1.062949	0.748555	0.706499	0.368395	0.420122	0.35072	0.107564	0.626119	0.626119			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	156	China	4	30	Eastern Asia	Country	104.1403375	32.30955217	CHN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	40.459119	35.27148	46.045016	59.738488	56.257444	51.782322	56.448754	102.788384	59.139588	105.879645	118.939449	73.682707	117.865615	92.477727	73.244972	81.841914	165.653958	141.109887	141.109887			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	17	Middle Africa	4	202	Sub-Saharan Africa	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	115.095961	122.047822	94.781618	97.300321	131.54832	176.374957	172.63628	210.72506	369.703942	368.819291	429.172913	494.149907	523.813827	629.590427	627.15146	730.101573	601.255759	658.637559	658.637559			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	170	Colombia	5	5	South America	Country	-73.07446751	3.888209046	COL	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	3.338234	1.001798	1.096039	0.431422	1.925985	1.262679	1.435117	1.483828	4.430475	3.418719	16.541843	13.927269	5.703264	10.60224	9.009707	4.525688	3.295007	10.830995	10.830995			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	174	Comoros	5	14	Eastern Africa	Country	43.34234565	-11.66121732	COM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.84727	1.278216	2.752107	3.409613	2.211562	0.838372	0.734036	0.551822	0.603684	1.536111	7.907759	4.236449	9.859491	6.998333	4.176528	2.311178	6.651591	2.372648	2.372648			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	175	Mayotte	5	14	Eastern Africa	Country	45.14015057	-12.82217691	MYT	0	1			[2004, 2005, 2006, 2007, 2008, 2009, 2010]	2004	2010	7	CON_USD	Constant USD	G	Global					4.731136	0.535355	0.376918	5.675699	6.09279	5.962657	1.881027								1.881027			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	178	Congo	5	11	Western Africa	Country	15.22052612	-0.840544119	COG	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	2.106737	1.170257	1.984118	3.757662	6.005704	2.299443	0.320057	3.712897	4.599428	4.261379	22.156191	16.630655	26.022675	17.231981	5.679247	9.523186	8.654609	7.511611	7.511611			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	18	Southern Africa	4	202	Sub-Saharan Africa	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	17.927114	70.663028	36.771131	35.017065	24.814881	29.60516	48.220626	47.382416	41.67885	62.573285	48.944046	123.397213	92.439565	166.366056	50.136129	104.814614	131.465139	197.780363	197.780363			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	180	Democratic Republic of the Congo	5	17	Middle Africa	Country	23.65496507	-2.877154732	COD	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	32.379885	39.826359	49.983714	46.457667	63.627354	76.677314	84.521566	109.708362	229.652922	245.215298	265.599882	304.479279	342.31899	389.671884	419.246503	518.224623	420.755394	433.093888	433.093888			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	184	Cook Islands	4	61	Polynesia	Country	-159.7711391	-21.22696458	COK	0	1			[2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2002	2017	16	CON_USD	Constant USD	G	Global			0.340232	0.980569	0.474088	0.003117	0.049814	0.086	0.073519	0.000199	0.059004	0.088258	0.053166	0.123606	0.051723	0.173554	0.088853	0.08313	0.08313			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	188	Costa Rica	5	13	Central America	Country	-84.19712782	9.970998683	CRI	1	1			[2000, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	17	CON_USD	Constant USD	G	Global	0.017866		0.250867	0.739461	0.869747	0.931007	3.013805	2.211006	3.655844	1.830115	1.056691	0.442649	0.399083	0.122429	0.383367	0.35754	0.054785	0.288464	0.288464			[2000]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	191	Croatia	4	39	Southern Europe	Country	17.95874553	45.45172212	HRV	1	1			[2000, 2001, 2003, 2004, 2005, 2007, 2008, 2009, 2010]	2000	2010	9	CON_USD	Constant USD	G	Global	0.019922	0.4247		0.123112	0.011994	0.011766		0.103259	0.017008	0.05727	0.079005								0.079005			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2003-2005,2007-2010]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	192	Cuba	5	29	Caribbean	Country	-79.54460144	22.10030366	CUB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	4.138365	3.724851	2.463137	3.402877	1.835288	2.40697	2.390821	1.91871	4.645297	2.925779	4.482882	3.472885	1.958018	1.728437	2.986156	2.041964	1.331993	0.723969	0.723969			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	199	Least Developed Countries (LDC)	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	790.504822	741.221778	620.906782	752.483034	928.050692	1277.661391	1551.98433	1744.9528	2199.125381	2322.94964	2709.712675	2790.468356	3318.074294	4255.604493	4068.654715	4525.172384	4081.026648	4803.157759	4803.157759			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	2	Africa	2	1	World	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	740.058847	910.719569	700.024137	795.149202	983.639921	1207.0198	1530.493139	1784.002916	2233.765059	2695.230299	2840.177876	3065.925909	3654.074072	4508.689195	4203.452766	5123.343292	4476.139044	5247.606361	5247.606361			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	202	Sub-Saharan Africa	3	2	Africa	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	676.889447	859.649889	636.692993	758.622995	926.818753	1092.787771	1428.42069	1627.176442	2056.221066	2581.911989	2676.510103	2943.181251	3522.190818	4370.833609	4096.0167	4989.67185	4251.876714	5124.63605	5124.63605			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	204	Benin	5	11	Western Africa	Country	2.339933594	9.65401646	BEN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	22.01314	6.090277	16.798397	15.616308	20.629694	23.02031	22.438529	27.959876	34.431175	44.825949	51.637585	54.629731	49.026495	60.477659	63.387584	48.145967	48.488937	87.991361	87.991361			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	212	Dominica	5	29	Caribbean	Country	-61.3493756	15.43391378	DMA	1	1			[2006, 2007, 2008, 2009, 2010, 2011, 2013, 2015, 2017]	2006	2017	9	CON_USD	Constant USD	G	Global							0.039338	0.045796	0.010668	0.029411	0.009708	0.058921		0.088014		0.09209		0.036037	0.036037			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	214	Dominican Republic	5	29	Caribbean	Country	-70.49847576	18.89832088	DOM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	3.398958	3.17804	7.139888	11.887903	3.466845	12.478652	8.7787	3.691808	5.611734	6.155474	10.701561	7.477802	9.395833	6.069934	5.818502	3.814113	2.595927	4.203762	4.203762			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	218	Ecuador	5	5	South America	Country	-78.37005241	-1.447785891	ECU	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	2.671484	5.777403	2.209788	2.271081	9.551949	15.770348	15.023421	23.454754	19.508584	10.257249	10.413142	9.262356	4.983465	5.306141	6.535338	2.805666	8.222837	7.851036	7.851036			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	222	El Salvador	5	13	Central America	Country	-88.86862995	13.73603564	SLV	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	12.268965	15.461543	8.240292	8.085354	5.786864	13.486623	12.946902	8.354169	8.728522	6.86101	7.55631	5.046987	4.626692	3.268843	2.457476	3.252596	4.957902	6.410242	6.410242			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	223	Eastern Asia (excluding Japan and China)	3	142	Asia	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	12.798319	2.064135	4.150705	2.640126	3.803825	6.501197	2.16741	13.55945	9.869376	20.971321	36.971108	33.836998	28.919815	33.100165	32.081978	28.965029	43.798716	36.559747	36.559747			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	226	Equatorial Guinea	5	17	Middle Africa	Country	10.46535826	1.565792376	GNQ	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	5.177526	3.849611	2.524236	3.128041	3.371955	4.469445	9.120103	5.40303	10.931124	6.036438	6.892314	6.979561	1.930281	0.495429	0.642291	0.986022	1.606307	2.540341	2.540341			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	231	Ethiopia	5	14	Eastern Africa	Country	39.63505296	8.631223181	ETH	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	19.544609	22.810748	53.103605	109.450023	57.713136	85.945564	172.730981	221.21962	131.8053	249.570727	192.643803	305.709496	323.235055	567.708223	406.779511	388.725345	366.76778	381.779053	381.779053			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	232	Eritrea	5	14	Eastern Africa	Country	38.11074289	16.12894644	ERI	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	31.908131	2.95713	14.809644	17.644586	11.229601	10.467892	5.780352	12.851981	8.727561	4.38172	27.875154	9.590789	11.103634	19.288286	14.474849	12.032982	12.271814	27.314576	27.314576			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	24	Angola	5	17	Middle Africa	Country	17.57817062	-12.33724746	AGO	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	20.89454	61.704055	18.18978	23.537603	10.640451	40.877585	24.653993	46.291082	66.694518	50.165286	55.579611	37.81569	67.629084	67.823572	46.634291	51.293492	45.613149	62.318426	62.318426			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	242	Fiji	4	54	Melanesia	Country	177.9660884	-17.83301566	FJI	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	2.485908	0.639764	6.594328	4.579938	4.652517	4.218836	0.693638	0.326461	1.262977	1.192026	3.772739	3.207928	9.830656	9.652715	9.724223	14.778509	6.530166	5.342901	5.342901			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	262	Djibouti	5	14	Eastern Africa	Country	42.18274707	11.56004161	DJI	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.205083	1.294696	1.66358	1.040921	3.142516	5.35177	6.879664	9.490851	8.363442	5.093166	3.819021	2.852605	7.721092	4.199014	3.906023	7.141695	11.384502	8.46984	8.46984			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	266	Gabon	5	17	Middle Africa	Country	11.78727747	-0.60687619	GAB	1	1			[2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2001	2017	17	CON_USD	Constant USD	G	Global		0.226645	0.101218	0.915499	3.306844	5.09545	8.633725	4.166976	2.944603	6.239373	2.139771	2.007242	1.618941	2.556592	2.083119	3.400998	4.502103	2.567265	2.567265			[2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	268	Georgia	4	145	Western Asia	Country	43.3713615	42.04813028	GEO	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	4.553602	8.423243	7.442501	4.564167	3.543564	4.737795	3.644808	14.361218	13.662084	9.709121	18.054543	17.485299	6.332702	8.715008	7.191256	4.068218	8.939976	8.017652	8.017652			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	270	Gambia	5	11	Western Africa	Country	-15.39944785	13.45295927	GMB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.469255	0.657676	1.481462	2.087941	3.505531	5.944334	4.776085	8.866893	7.761484	7.764204	15.547715	18.357367	21.529266	23.841433	18.108542	19.989072	25.76374	49.89267	49.89267			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	275	State of Palestine	4	145	Western Asia	Country	35.25694122	31.94347933	PSE	0	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	29.877942	16.334945	14.795251	38.497354	59.410668	54.963096	62.559366	50.415451	63.26121	64.445985	74.369765	67.928015	74.278265	49.138426	73.848964	97.613292	79.152748	160.001992	160.001992			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	28	Antigua and Barbuda	5	29	Caribbean	Country	-61.7999755	17.07761471	ATG	1	1			[2002, 2015, 2017]	2002	2017	3	CON_USD	Constant USD	G	Global			0.229772													0.003895		0.042017	0.042017			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	288	Ghana	5	11	Western Africa	Country	-1.205623522	7.964825185	GHA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	16.614835	30.730071	18.986761	28.158738	22.118743	42.973891	36.076574	54.644112	88.558883	111.55967	126.991171	97.528266	167.377562	148.213308	122.713372	148.649308	141.366742	131.389819	131.389819			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	29	Caribbean	4	419	Latin America and the Caribbean	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	23.379139	17.253581	14.121159	19.877659	19.695711	24.000069	36.815621	27.452196	41.962917	25.061892	32.215005	85.710622	66.568758	70.669129	52.808626	64.841327	106.689724	105.390387	105.390387			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	296	Kiribati	4	57	Micronesia	Country	-157.5643005	1.768837732	KIR	1	1			[2000, 2002, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	15	CON_USD	Constant USD	G	Global	0.08751		0.117425			2.1099	1.229299	0.848146	0.155613	1.484052	0.241366	0.253089	1.750432	1.064831	0.809534	1.117218	1.088468	2.59602	2.59602			[2000]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002,2005-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	30	Eastern Asia	3	142	Asia	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	53.257438	37.335615	50.195721	62.378614	60.061269	58.283519	58.616164	116.347834	69.008964	126.850966	155.910557	107.519705	146.78543	125.577892	105.32695	110.806943	209.452674	177.669634	177.669634			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	308	Grenada	5	29	Caribbean	Country	-61.68248568	12.11238395	GRD	1	1			[2003, 2004, 2005, 2006, 2007, 2008, 2009, 2013, 2015, 2016, 2017]	2003	2017	11	CON_USD	Constant USD	G	Global				0.066416	0.034469	0.006052	0.07947	0.24335	0.142826	0.126684				0.024517		0.018073	0.005263	0.020179	0.020179			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	31	Azerbaijan	4	145	Western Asia	Country	50.01064725	40.39229544	AZE	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	8.399359	1.768438	0.675741	0.96936	1.476153	4.62423	2.572983	7.831363	5.949031	8.75899	8.722582	12.942884	4.130763	10.188328	7.754838	5.374061	3.880628	8.357606	8.357606			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	32	Argentina	5	5	South America	Country	-65.14563274	-35.19446255	ARG	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.068039	0.191553	1.001813	3.682038	2.103392	1.948171	6.66561	2.676392	29.694213	13.73302	17.070734	5.829823	0.794423	0.710314	0.658928	0.843212	0.574687	1.2962	1.2962			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	320	Guatemala	5	13	Central America	Country	-91.2312746	15.00273719	GTM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	4.410687	6.485736	16.022956	21.691009	4.763974	16.082576	22.560063	26.017853	25.367731	21.096899	16.499626	28.838516	20.70733	26.575299	26.288735	47.731169	21.788718	25.356877	25.356877			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	324	Guinea	5	11	Western Africa	Country	-11.28173419	11.00210343	GIN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	4.972042	5.550864	6.269567	4.935933	6.45673	7.783942	6.201097	8.784476	9.277262	9.979121	24.171122	7.635375	29.899482	16.286239	96.338339	142.277689	104.549556	79.679753	79.679753			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	328	Guyana	5	5	South America	Country	-58.97322037	4.788012784	GUY	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.38147	5.150645	0.062294	0.761747	7.143305	2.692244	1.386976	1.530568	1.272677	3.263685	4.760691	2.341115	2.720127	1.705783	1.130202	1.830922	2.247607	3.576092	3.576092			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	332	Haiti	5	29	Caribbean	Country	-72.33640958	18.40426539	HTI	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	15.516538	9.616255	2.446222	4.372351	13.86957	7.996975	21.676631	17.891327	28.870153	13.443636	15.544278	73.646589	54.220651	62.190774	42.478125	58.271203	101.452763	97.144774	97.144774			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	34	Southern Asia	3	142	Asia	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	469.983552	273.15092	393.950152	331.097862	383.003136	594.212462	711.318569	765.281989	764.108464	804.140041	1021.818664	791.700669	893.868516	1253.579885	930.595471	1140.051564	1208.012726	1214.432781	1214.432781			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	340	Honduras	5	13	Central America	Country	-86.59974381	14.82243161	HND	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	4.767786	5.766266	8.936027	7.522768	15.207945	20.255048	12.929373	17.729686	26.813916	22.904473	28.876992	23.720508	30.537762	15.659153	26.807715	36.589405	27.147939	10.783741	10.783741			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	35	South-Eastern Asia	3	142	Asia	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	197.574254	139.309452	114.912697	147.653161	132.891009	219.332775	305.360304	324.719887	348.855418	380.42926	514.082329	417.590943	549.519177	561.47652	504.573378	516.451934	530.433573	809.047124	809.047124			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	356	India	4	34	Southern Asia	Country	79.3608464	22.34642074	IND	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	319.303664	128.539582	283.659305	201.651643	192.943392	283.525093	257.2369	244.548532	209.416607	186.059721	268.734865	295.697612	248.203348	367.745835	237.29194	396.265675	377.706719	284.477865	284.477865			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	360	Indonesia	4	35	South-Eastern Asia	Country	113.9174	-0.994582204	IDN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	91.133179	34.889723	40.864043	61.892773	47.121869	61.980943	98.281899	105.080624	129.428494	116.702466	111.702049	105.753532	175.60862	146.65686	75.386538	101.028856	135.76227	365.13818	365.13818			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	364	Iran (Islamic Republic of)	4	34	Southern Asia	Country	54.19766348	32.74370885	IRN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.537926	0.374105	0.301052	0.294376	0.676224	0.813194	0.752049	0.747083	4.068152	0.125562	5.066012	4.684273	10.222546	4.956547	4.085945	3.527104	2.739568	1.645011	1.645011			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	368	Iraq	4	145	Western Asia	Country	43.76606267	33.05013795	IRQ	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	2.204918	4.169361	1.434166	27.753624	74.060386	502.178831	396.656824	218.455043	61.79632	70.86673	50.679334	14.938563	5.10654	23.303348	11.841484	11.858954	4.866633	6.619209	6.619209			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	384	Cte d'Ivoire	5	11	Western Africa	Country	-5.552690016	7.62211586	CIV	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	2.614862	2.368287	3.978888	5.363885	14.539935	10.603343	28.038643	18.747193	20.143304	32.470909	70.545148	27.600973	35.188912	59.421042	73.642275	52.3736	102.120207	96.732325	96.732325			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	388	Jamaica	5	29	Caribbean	Country	-77.31068409	18.15616857	JAM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.31314	0.383639	0.057832	0.071433	0.232753	0.675823	3.224085	3.300733	2.131452	1.48586	1.414641	0.709419	0.470945	0.140408	0.072173	0.181623	0.104617	2.665823	2.665823			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	39	Southern Europe	3	150	Europe	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	33.386088	29.643404	17.324735	24.069344	15.556845	29.147872	39.8765	31.489461	23.47871	8.349846	16.293492	15.468172	11.121803	10.915564	15.438763	9.791033	40.743396	62.719713	62.719713			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	398	Kazakhstan	4	143	Central Asia	Country	66.65359159	48.01963494	KAZ	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	2.795185	3.283574	9.215513	10.544721	6.196673	6.275151	6.565948	5.571691	5.384933	18.875969	27.297285	17.446134	12.85099	7.163735	8.775187	4.336182	6.581087	11.622033	11.622033			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	4	Afghanistan	4	34	Southern Asia	Country	66.02688198	33.83160199	AFG	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	6.913959	24.083604	19.913865	24.259662	82.337902	151.549691	155.760517	227.23888	191.624965	197.334703	128.013506	138.507481	145.089474	222.588642	241.517256	171.426352	205.750142	202.397253	202.397253			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	400	Jordan	4	145	Western Asia	Country	37.13024774	30.65365973	JOR	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	7.735966	0.787074	13.943965	1.486534	0.915964	25.920038	19.07749	20.371943	20.996724	25.58344	38.261531	21.369377	30.685859	20.500979	24.90784	38.111018	27.014208	39.276231	39.276231			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	404	Kenya	5	14	Eastern Africa	Country	37.86096816	0.534797278	KEN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	59.83851	80.892664	39.649248	33.471857	34.405656	55.496137	102.600357	64.553444	81.668436	119.20142	181.203784	190.141058	181.24872	191.931945	200.584017	194.089943	165.537166	247.495797	247.495797			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	408	Democratic People's Republic of Korea	4	30	Eastern Asia	Country	127.1803633	40.1462645	PRK	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	1.555752	1.868722	3.12479	1.533542	2.956228	3.627621	0.896207	4.217498	3.613903	15.485689	28.04611	16.276259	16.932956	22.916693	25.714758	23.914456	23.328546	24.916844	24.916844			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	417	Kyrgyzstan	4	143	Central Asia	Country	74.52324839	41.46204516	KGZ	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	1.493438	11.23943	6.269016	8.466219	9.135369	11.826949	11.419914	11.283169	13.917758	10.014437	11.00077	19.611596	19.279512	15.978885	24.26486	21.597651	17.648127	24.663068	24.663068			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	418	Lao People's Democratic Republic	4	35	South-Eastern Asia	Country	101.9901968	20.27482773	LAO	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	39.094848	23.628577	8.651986	10.018004	9.414022	21.838488	17.402912	20.658302	25.011667	17.416511	25.489687	28.130179	34.415191	39.214297	35.001806	32.004197	0.590356	32.095371	32.095371			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	419	Latin America and the Caribbean	3	19	Americas	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	143.28825	128.059388	103.004372	135.595806	135.159011	218.384165	239.81359	248.638299	281.319969	248.775324	261.148013	274.221963	246.373431	233.949685	185.521508	232.42953	250.890113	264.961828	264.961828			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	422	Lebanon	4	145	Western Asia	Country	35.89391711	33.92152458	LBN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	3.576716	2.87673	1.491251	2.415504	3.36617	16.75584	25.69176	25.326716	17.389638	20.145999	21.318157	18.868501	21.224769	24.106361	41.941008	30.122968	35.947072	39.188455	39.188455			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	426	Lesotho	5	18	Southern Africa	Country	28.25362195	-29.58041814	LSO	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	3.479648	1.890118	2.714453	3.716317	2.4513	1.595192	0.81354	2.719683	5.92359	3.44267	19.373604	33.860862	28.799321	68.543716	3.507472	2.355388	14.852392	31.295107	31.295107			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	430	Liberia	5	11	Western Africa	Country	-9.311879038	6.448381009	LBR	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	6.652705	3.297279	4.31041	8.056298	11.95314	9.997141	13.565957	6.352337	27.774313	39.7027	47.392006	53.077752	67.321373	58.332297	118.060331	214.352202	68.926459	65.227504	65.227504			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	432	Landlocked developing countries (LLDCs)	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	416.839243	431.126657	330.246531	473.802599	529.654265	688.603923	876.954653	1093.660756	1109.966522	1277.196875	1348.735589	1557.889298	1831.343636	2272.711788	1967.716364	2088.464166	2332.586989	2550.366273	2550.366273			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	434	Libya	4	15	Northern Africa	Country	18.0295985	27.04042819	LBY	1	1			[2005, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2005	2017	12	CON_USD	Constant USD	G	Global						0.212886		0.028657	21.667845	16.078384	0.564963	2.754772	0.512219	3.396375	0.090848	0.011278	0.468364	5.681431	5.681431			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	450	Madagascar	5	14	Eastern Africa	Country	46.6982339	-19.38514785	MDG	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	6.345843	13.390139	14.753501	18.505178	25.542078	46.022875	34.892668	51.154009	54.378499	49.908544	106.643071	59.622691	58.138589	103.608862	83.068826	114.619432	0.747117	82.429694	82.429694			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	454	Malawi	5	14	Eastern Africa	Country	33.4884625	-13.40819859	MWI	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	36.728667	15.81861	24.849549	33.545725	29.50743	10.831137	26.120423	43.84384	78.686845	58.537664	59.88309	148.357442	154.783411	161.04231	119.288547	163.623245	232.046928	289.558811	289.558811			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	458	Malaysia	4	35	South-Eastern Asia	Country	116.8346314	5.452415309	MYS	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.019899	0.035534	0.43565	0.157789	0.430882	0.325829	0.041132	0.004464	0.037581	0.120551	0.030224	0.311751	0.373727	0.366114	0.381129	0.585056	1.448551	2.528966	2.528966			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	462	Maldives	4	34	Southern Asia	Country	73.09672546	-0.614385021	MDV	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.241879	0.19615	0.174732	0.138843	0.358546	0.524763	0.069812	0.204606	0.404737	0.145278	0.255075	0.695213	0.441253	0.350451	0.534406	1.073036	0.560795	0.620256	0.620256			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	466	Mali	5	11	Western Africa	Country	-3.522016039	17.35311254	MLI	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	28.568076	31.960871	9.116752	16.676273	22.39898	32.503134	31.84216	37.044241	50.395517	71.600721	100.692368	109.721784	98.927891	107.881696	95.437294	135.602179	138.973601	131.354835	131.354835			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	478	Mauritania	5	11	Western Africa	Country	-10.33187259	20.26089546	MRT	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	4.25623	3.281649	4.626523	5.02101	6.024414	2.988158	2.96741	9.710411	9.034117	7.046162	7.537241	5.664342	2.974245	10.517075	13.322376	13.587167	11.086956	16.198968	16.198968			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	48	Bahrain	4	145	Western Asia	Country	50.5490754	26.04407747	BHR	1	1			[2002]	2002	2002	1	CON_USD	Constant USD	G	Global			0.004032																0.004032			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	480	Mauritius	5	14	Eastern Africa	Country	57.568022	-20.28581998	MUS	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	14	CON_USD	Constant USD	G	Global	0.093589	0.042641	0.043107	0.029031	0.019836	0.019459	0.208334					0.214178	0.074397	0.323629	0.084109	0.179324	0.360935	1.096305	1.096305			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2006,2011-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	484	Mexico	5	13	Central America	Country	-102.5148166	23.93378032	MEX	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	5.85214	6.741006	4.293883	3.764404	6.050119	6.234004	8.431412	11.902893	3.619958	6.633156	3.514379	3.195675	3.866139	2.857974	1.731952	0.993103	1.661582	4.022106	4.022106			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	496	Mongolia	4	30	Eastern Asia	Country	103.0728057	46.83892054	MNG	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	11.242567	0.195413	1.025915	1.106584	0.847597	2.873576	1.271203	9.341952	6.255473	5.485632	8.924998	17.560739	11.986859	10.183472	6.36722	5.050573	20.47017	11.642903	11.642903			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	498	Republic of Moldova	4	151	Eastern Europe	Country	28.4650624	47.20236795	MDA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	10.12241	1.303986	1.289975	1.035606	1.806856	2.853979	3.458394	6.474057	12.631047	18.540025	16.940226	24.436237	25.296573	23.8168	12.268032	11.461417	14.389922	12.79485	12.79485			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	499	Montenegro	4	39	Southern Europe	Country	19.25214024	42.78717043	MNE	1	1			[2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2004	2017	14	CON_USD	Constant USD	G	Global					0.168812	0.271912	2.454789	5.461546	3.32853	0.805157	0.723622	0.166458	0.267916	0.23502	0.1924	0.089004	1.190694	0.046865	0.046865			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	5	South America	4	419	Latin America and the Caribbean	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	82.078386	62.46303	44.563233	65.522197	68.319084	113.967055	114.167769	121.070389	140.327982	138.24642	146.217273	110.722107	95.489845	88.554749	51.289057	52.120681	61.058551	75.301005	75.301005			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	50	Bangladesh	4	34	Southern Asia	Country	89.17660788	22.86961622	BGD	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	92.500884	36.009137	41.562424	37.062303	34.805594	61.012991	145.264081	66.871914	146.910185	145.424319	180.825102	152.383147	127.906852	255.700407	145.191487	222.189033	206.485987	225.689014	225.689014			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	500	Montserrat	5	29	Caribbean	Country	-62.19261223	16.73558313	MSR	0	1			[2008, 2009, 2011, 2013, 2014]	2008	2014	5	CON_USD	Constant USD	G	Global									0.168063	0.405232		0.157807		0.195643	0.781955				0.781955			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	504	Morocco	4	15	Northern Africa	Country	-6.281942841	31.8440131	MAR	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	3.420541	4.644354	8.122863	8.511803	5.935005	5.880465	2.454734	17.719135	7.099979	6.338354	23.065763	19.424036	4.277934	10.141617	9.330117	4.002649	69.01545	22.078228	22.078228			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	508	Mozambique	5	14	Eastern Africa	Country	38.18479941	-14.27963886	MOZ	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	121.819962	69.076467	62.450385	41.447063	58.737271	51.658124	60.172293	66.113501	89.904184	73.776849	115.77597	121.976973	155.588523	201.507594	244.417515	243.940958	237.454689	230.117212	230.117212			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	51	Armenia	4	145	Western Asia	Country	44.93839317	40.29499741	ARM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	7.414221	0.36318	2.809129	2.153153	0.87671	6.677151	12.586182	15.546248	9.82247	12.519035	14.266977	10.456848	8.795569	9.35965	5.660223	5.499856	14.974564	6.200256	6.200256			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	512	Oman	4	145	Western Asia	Country	57.87743482	21.98805614	OMN	1	1			[2000, 2001, 2002, 2003]	2000	2003	4	CON_USD	Constant USD	G	Global	0.377391	0.23879	0.256906	0.257541															0.257541			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2003]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	514	Developed Regions	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	43.508498	30.94739	18.61471	25.10495	17.363701	41.292194	58.700846	51.91379	51.534139	35.748148	47.573162	63.371789	62.579886	60.930125	64.461943	74.51142	127.0765	112.574384	112.574384			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	515	Developing Regions	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	2179.075235	1963.544401	2135.054115	2223.418132	2656.667198	3895.885754	4398.411106	5336.142012	5314.001348	6146.89611	6771.307143	6428.420497	7229.153435	8801.606835	8013.485619	9496.946127	9546.40019	11085.631099	11085.631099			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	516	Namibia	5	18	Southern Africa	Country	17.21907885	-22.13817068	NAM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	1.1333	0.25708	0.746067	1.111275	2.056756	2.850703	7.263009	10.163644	3.668775	12.848166	4.640313	5.055716	6.04905	7.904483	8.9937	4.143686	10.024327	13.6111	13.6111			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	52	Barbados	5	29	Caribbean	Country	-59.5346489	13.13648273	BRB	1	1			[2004, 2006, 2009, 2010]	2004	2010	4	CON_USD	Constant USD	G	Global					0.004745		0.008392			0.031787	0.009708								0.009708			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	520	Nauru	4	57	Micronesia	Country	166.92313	-0.528742623	NRU	1	1			[2005, 2006, 2007, 2008, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2005	2017	11	CON_USD	Constant USD	G	Global						0.235819	0.196738	0.705477	0.163561			0.015046	0.195021	0.22238	0.086049	8.04957	0.52318	0.449542	0.449542			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	524	Nepal	4	34	Southern Asia	Country	83.94678863	28.25866332	NPL	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	16.672649	38.345361	21.574805	20.239996	15.721329	19.912881	24.09576	38.76258	40.999676	37.109283	77.10544	55.316487	54.578873	76.050451	106.312035	100.115037	72.53414	61.373203	61.373203			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	54	Melanesia	3	9	Oceania	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	132.881151	3.858374	77.001219	58.946488	52.092708	45.068203	27.639943	36.981802	59.715981	78.823042	43.064146	58.503363	59.58104	78.651996	43.0035	105.624405	49.188856	58.750493	58.750493			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	548	Vanuatu	4	54	Melanesia	Country	167.0679779	-15.34445547	VUT	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.504099	0.298964	0.375177	0.923187	0.714778	0.776353	0.481608	0.938839	3.268706	5.088511	3.935813	6.413868	5.305073	8.300456	5.238309	5.799874	2.002431	4.09506	4.09506			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	558	Nicaragua	5	13	Central America	Country	-85.03060315	12.84210839	NIC	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	8.167949	13.711212	6.387746	7.850229	13.990179	22.925392	28.287101	33.41542	30.164244	25.245864	24.112622	15.822666	23.336533	24.888378	21.511243	19.989384	22.468107	30.613279	30.613279			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	562	Niger	5	11	Western Africa	Country	9.400167877	17.42143036	NER	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	2.109576	2.189214	5.995351	11.204018	17.16025	23.532003	43.318241	28.800898	50.747036	50.824717	63.841648	45.356837	31.000454	54.454918	83.331278	68.202077	73.266224	86.838137	86.838137			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	566	Nigeria	5	11	Western Africa	Country	8.097363256	9.585789025	NGA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	18.804623	119.4315	54.793277	57.612443	95.279256	75.778663	122.510136	173.636896	224.128752	468.054387	180.078357	248.828922	322.792614	520.338112	437.803853	708.208802	541.902479	669.094481	669.094481			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	57	Micronesia	3	9	Oceania	Region								[2000, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	17	CON_USD	Constant USD	G	Global	0.08751		0.117425	8.187809	1.008312	3.536223	2.380733	1.734278	1.233677	2.429278	0.836855	0.828459	2.377031	2.395358	1.483992	9.923182	2.134483	3.869591	3.869591			[2000]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	570	Niue	4	61	Polynesia	Country	-169.8601693	-19.05000475	NIU	0	1			[2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2002	2017	16	CON_USD	Constant USD	G	Global			0.219796	0.000495	0.131723	5.441319	0.97289	0.399304	0.494466	0.265647	0.210132	0.030957	0.013307	0.160054	0.013244	0.027731	0.009924	0.048704	0.048704			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	583	Micronesia (Federated States of)	4	57	Micronesia	Country	158.225216	6.880670092	FSM	1	1			[2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2003	2017	15	CON_USD	Constant USD	G	Global				4.869023	0.02669	0.053897	0.071679	0.066489	0.047964	0.065394	0.233372	0.188078	0.182791	0.561074	0.402472	0.380069	0.380926	0.541019	0.541019			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	584	Marshall Islands	4	57	Micronesia	Country	171.0839119	7.110213497	MHL	1	1			[2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2003	2017	15	CON_USD	Constant USD	G	Global				2.388806	0.105573	0.230992	0.105618	0.088825	0.11606	0.084908	0.108827	0.324095	0.203536	0.334861	0.161138	0.216972	0.141909	0.200195	0.200195			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	585	Palau	4	57	Micronesia	Country	134.5733878	7.502307591	PLW	1	1			[2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2017]	2003	2017	14	CON_USD	Constant USD	G	Global				0.92998	0.876049	0.905615	0.777399	0.025341	0.750479	0.794924	0.25329	0.048151	0.045251	0.212212	0.024799	0.159353		0.082815	0.082815			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	586	Pakistan	4	34	Southern Asia	Country	68.80479684	29.36491634	PAK	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	24.036311	29.851146	23.409988	35.996335	42.974642	60.159796	114.243046	173.300126	151.043273	216.007767	330.804289	126.786695	285.103028	306.751338	169.91771	207.148539	319.466775	386.636731	386.636731			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	591	Panama	5	13	Central America	Country	-81.26616623	8.450965746	PAN	1	1			[2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2001	2017	17	CON_USD	Constant USD	G	Global		0.177014	0.037422	0.51288	0.472338	0.451611	0.60991	0.471992	0.671322	0.885107	0.290638	0.173548	0.348944	0.671645	1.041031	3.298395	1.899524	4.747661	4.747661			[2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	598	Papua New Guinea	4	54	Melanesia	Country	145.8587761	-6.756057077	PNG	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	122.806352	1.005886	69.707085	53.193522	45.928242	38.731573	26.315326	34.627976	38.690912	54.355942	26.186746	43.173629	39.428196	36.111907	23.207503	66.931703	24.041118	44.942484	44.942484			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	600	Paraguay	5	5	South America	Country	-60.54854225	-21.70216237	PRY	1	1			[2000, 2001, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	17	CON_USD	Constant USD	G	Global	0.320489	0.57712		0.184845	0.698377	1.421862	1.686225	8.177873	7.61664	4.716625	11.117453	4.348743	6.509827	4.747829	3.520118	5.751441	6.20926	7.726256	7.726256			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2003-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	604	Peru	5	5	South America	Country	-71.82093277	-13.58939705	PER	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	13.134122	10.56365	18.05177	15.057609	14.216414	45.446275	28.610573	22.038509	31.044235	58.455412	31.409637	21.279485	38.647217	33.148318	10.480025	9.780312	14.975798	12.297021	12.297021			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	608	Philippines	4	35	South-Eastern Asia	Country	120.8601418	14.16591706	PHL	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	18.279809	17.305446	16.532303	16.164879	20.901052	11.816747	24.865109	50.444446	27.475175	39.819817	81.10392	60.416161	32.07021	39.26873	55.113951	98.766248	72.918928	75.612001	75.612001			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	61	Polynesia	3	9	Oceania	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.000991	5.727387	5.085923	3.737477	1.317476	13.492481	4.024471	3.520263	1.988635	1.079641	6.755175	12.838149	6.463049	8.109711	1.750202	7.870874	10.106503	8.876808	8.876808			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	624	Guinea-Bissau	5	11	Western Africa	Country	-14.40182514	12.11760394	GNB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.473442	5.115513	2.180102	1.281603	3.136101	3.639841	3.015	5.806495	5.764246	5.345731	19.956506	6.130582	14.841004	34.43545	10.938113	18.875008	20.831707	22.27318	22.27318			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	626	Timor-Leste	4	35	South-Eastern Asia	Country	125.9451052	-8.797497247	TLS	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	2.349742	6.60028	1.121917	2.408697	3.348958	7.832243	17.653875	11.921107	9.746192	9.875072	8.080728	3.202681	13.688961	6.981062	11.27069	14.186339	15.870933	12.041917	12.041917			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	64	Bhutan	4	34	Southern Asia	Country	90.45098484	27.39598568	BTN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	3.669837	0.855254	0.559183	4.716056	2.84576	5.543321	3.626088	2.058589	2.186269	1.923484	1.036402	1.985905	2.095707	1.886059	3.128764	4.084119	2.084903	2.577695	2.577695			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	646	Rwanda	5	14	Eastern Africa	Country	29.92310194	-1.999842114	RWA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	13.366361	8.979774	22.445098	11.948223	25.562433	30.958943	60.425925	38.793921	79.96432	88.331375	70.354501	73.326879	75.813594	83.327703	102.612126	84.899557	80.960525	87.449944	87.449944			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	659	Saint Kitts and Nevis	5	29	Caribbean	Country	-62.76628613	17.33994219	KNA	1	1			[2002, 2003, 2009]	2002	2009	3	CON_USD	Constant USD	G	Global			1.749404	0.024285						0.025783									0.025783			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	660	Anguilla	5	29	Caribbean	Country	-63.05651612	18.21525315	AIA	0	1			[2000, 2001, 2002, 2013]	2000	2013	4	CON_USD	Constant USD	G	Global	0.012138	0.252577	0.029592											0.001292					0.001292			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002,2013]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	662	Saint Lucia	5	29	Caribbean	Country	-60.96529553	13.89405601	LCA	1	1			[2003, 2004, 2005, 2006, 2007, 2008, 2009, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2003	2017	14	CON_USD	Constant USD	G	Global				0.048516	0.080234	0.088436	0.278142	0.114364	0.157515	0.120863		0.187199	0.041459	0.06645	0.472282	0.195867	1.158679	0.549301	0.549301			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	670	Saint Vincent and the Grenadines	5	29	Caribbean	Country	-61.19024321	13.24627968	VCT	1	1			[2001, 2004, 2005, 2006, 2007, 2008, 2009, 2012, 2013, 2014, 2015, 2016, 2017]	2001	2017	13	CON_USD	Constant USD	G	Global		0.095438			0.004745	0.093272	0.26244	0.243344	0.225209	0.283629			0.481852	0.16366	0.199433	0.222499	0.040482	0.004525	0.004525			[2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2004-2009,2012-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	678	Sao Tome and Principe	5	17	Middle Africa	Country	6.609772265	0.241554875	STP	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.209635	0.458361	0.230053	0.18828	0.201789	2.027304	2.632026	2.046719	4.621075	2.311818	3.255735	5.158006	2.750018	5.481181	4.854862	3.742314	5.084243	6.220655	6.220655			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	68	Bolivia (Plurinational State of)	5	5	South America	Country	-64.66224284	-16.71273412	BOL	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	60.977573	34.11692	18.276804	39.029375	19.432612	28.669838	46.616388	44.978028	29.891064	21.392457	29.026171	30.465421	28.301822	20.465448	16.229472	21.632159	19.002463	21.327574	21.327574			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	682	Saudi Arabia	4	145	Western Asia	Country	44.54763347	24.12594211	SAU	1	1			[2001]	2001	2001	1	CON_USD	Constant USD	G	Global		0.012714																	0.012714			Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	686	Senegal	5	11	Western Africa	Country	-14.46636926	14.35920905	SEN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	5.332569	24.700063	19.91309	25.558684	45.177058	39.359099	81.179885	33.170109	56.561625	60.896648	54.351854	53.614335	94.673498	72.630735	109.299407	85.448991	84.303353	71.786447	71.786447			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	688	Serbia	4	39	Southern Europe	Country	20.805876	44.03145697	SRB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	14.790956	11.544	4.775882	4.17515	2.337913	8.939658	7.361573	4.371728	6.740296	0.996998	2.533142	1.851721	1.360371	1.679639	1.957994	1.188904	0.534764	25.162644	25.162644			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	690	Seychelles	5	14	Eastern Africa	Country	55.46561591	-4.678053059	SYC	1	1			[2004, 2005, 2007, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2004	2017	10	CON_USD	Constant USD	G	Global					0.75562	0.741261		0.004942				0.099043	0.188232	0.245047	0.154275	0.154123	3.278389	0.017649	0.017649			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	694	Sierra Leone	5	11	Western Africa	Country	-11.78306584	8.568604164	SLE	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	2.748483	2.184923	2.900483	7.284651	8.822385	12.530035	19.038247	19.654112	22.480597	24.407628	32.481899	25.155719	23.586166	29.463921	101.366635	143.608383	84.093569	65.896775	65.896775			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	70	Bosnia and Herzegovina	4	39	Southern Europe	Country	17.78584332	44.16845548	BIH	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	8.840807	5.229154	5.307253	8.983114	4.459384	4.709645	17.530747	10.995622	6.579137	2.509616	7.49959	5.845886	6.429865	5.394076	10.65323	5.036912	35.934389	34.211435	34.211435			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	704	Viet Nam	4	35	South-Eastern Asia	Country	105.802499	10.09643079	VNM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	18.849144	23.900437	27.27009	16.702466	19.001151	42.931043	54.255486	51.464464	59.082026	69.548312	110.419733	95.998533	130.962643	124.28599	89.351167	75.249613	80.409343	88.074842	88.074842			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	706	Somalia	5	14	Eastern Africa	Country	46.20367477	4.406485729	SOM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	5.119033	5.936456	5.913903	4.134451	13.30292	12.336308	14.331552	18.215718	17.271919	25.175994	25.103997	25.955859	51.79348	53.968218	62.254024	55.647584	51.305311	55.147903	55.147903			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	710	South Africa	5	18	Southern Africa	Country	24.67184355	-29.99957544	ZAF	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	12.789597	68.001738	32.204306	28.83781	19.130182	24.423647	36.153051	30.95387	29.096612	36.469694	16.213123	67.994021	49.8591	79.300488	30.609084	88.88488	88.439567	121.660897	121.660897			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	716	Zimbabwe	5	14	Eastern Africa	Country	29.86909584	-19.00075492	ZWE	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	2.414117	3.207561	1.206033	8.60402	3.456494	8.965153	7.81816	47.112085	34.524962	62.607765	86.292707	56.841478	113.301167	83.808731	62.71801	120.488073	81.047816	148.510187	148.510187			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	72	Botswana	5	18	Southern Africa	Country	23.81380223	-22.18810073	BWA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2017]	2000	2017	17	CON_USD	Constant USD	G	Global	0.396691	0.406068	0.868442	0.285997	0.489715	0.457297	3.206135	2.444959	2.433565	2.068257	4.633672	4.00333	2.857304	3.479552	3.984223	3.592419		17.514755	17.514755			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2015,2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	722	Small island developing States (SIDS)	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	163.530723	49.882818	103.396652	99.270917	92.730443	106.937944	97.018737	90.749514	129.678791	135.158723	134.806771	185.449243	186.576322	221.470194	135.787646	238.199932	224.544474	230.930443	230.930443			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	728	South Sudan	5	14	Eastern Africa	Country	30.32618773	7.290839152	SSD	1	1			[2011, 2012, 2013, 2014, 2015, 2016, 2017]	2011	2017	7	CON_USD	Constant USD	G	Global												44.628246	98.50753	82.59352	93.099438	118.059684	61.2154	173.410103	173.410103			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	729	Sudan	4	15	Northern Africa	Country	29.95650159	16.02643066	SDN	0	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	12.334091	13.899996	18.303851	16.03848	34.759683	82.93281	52.480512	72.396499	96.604587	71.56485	117.899568	82.843844	112.4283	116.858348	88.920286	111.292919	134.257068	85.005402	85.005402			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	740	Suriname	5	5	South America	Country	-55.90626394	4.132603197	SUR	1	1			[2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2002	2017	16	CON_USD	Constant USD	G	Global			0.042204	0.308367	0.009574	2.699444	0.908473	1.502344	2.47036	4.705444	5.436967	1.827215	1.231202	1.25742	0.690061	1.798733	0.626347	2.782723	2.782723			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	748	Eswatini	5	18	Southern Africa	Country	31.50149288	-26.56471011	SWZ	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.127878	0.108024	0.237863	1.065666	0.686928	0.278321	0.784891	1.10026	0.556308	7.744498	4.083334	12.483284	4.87479	7.137817	3.04165	5.838241	18.148853	13.698504	13.698504			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	76	Brazil	5	5	South America	Country	-53.08432878	-10.77668561	BRA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.445041	4.880584	3.118616	2.767592	10.640572	10.787857	10.677045	12.121805	12.563137	15.377448	15.685456	19.634381	4.944642	8.926974	2.054195	2.480373	5.560678	5.834614	5.834614			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	760	Syrian Arab Republic	4	145	Western Asia	Country	38.50466565	35.01676176	SYR	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.696879	2.759522	3.232046	0.482806	3.941644	7.296756	8.169793	9.559151	14.114771	21.272105	13.970487	13.727543	8.713422	5.281301	4.936278	11.250747	13.459986	29.027765	29.027765			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	762	Tajikistan	4	143	Central Asia	Country	69.294998	38.43069666	TJK	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	4.701885	1.577368	6.705906	8.732765	12.800889	6.877358	13.456285	14.44137	23.180656	17.482421	28.017901	24.340126	27.333843	23.336163	30.193443	24.613079	27.021533	37.396311	37.396311			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	764	Thailand	4	35	South-Eastern Asia	Country	101.0202951	15.13089239	THA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	1.631992	0.079115	0.454933	1.301721	9.296897	15.823136	39.066839	11.725047	19.006097	20.669257	15.841796	33.246665	15.059103	24.469124	30.453141	27.28324	26.188471	37.803386	37.803386			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	768	Togo	5	11	Western Africa	Country	0.97835765	8.532096072	TGO	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	15.501333	2.489733	2.147376	3.620628	8.060741	9.401297	5.641021	11.964775	18.730241	14.704214	20.045494	30.640791	7.490191	31.491932	20.386929	16.715415	37.415049	44.14547	44.14547			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	772	Tokelau	4	61	Polynesia	Country	-171.8154473	-9.214545558	TKL	0	1			[2003, 2011, 2013, 2014, 2015, 2016, 2017]	2003	2017	7	CON_USD	Constant USD	G	Global				0.253334								0.021244		0.012822	0.014619	0.019757	0.029073	0.028832	0.028832			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	776	Tonga	4	61	Polynesia	Country	-175.1959991	-21.19511329	TON	1	1			[2000, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	16	CON_USD	Constant USD	G	Global	0.000991			0.192146	0.423478	6.877621	1.966764	0.10232	0.141211	0.083316	1.987254	10.820755	3.948471	0.678081	0.624832	1.813473	5.077008	3.896168	3.896168			[2000]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2003-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	780	Trinidad and Tobago	5	29	Caribbean	Country	-61.29389504	10.41877263	TTO	1	1			[2001, 2002, 2003, 2004, 2005, 2006, 2007, 2009, 2010]	2001	2010	9	CON_USD	Constant USD	G	Global		0.002781	0.005312	0.003878	0.075547	0.05851	0.077602	0.002764		0.027754	0.052227								0.052227			[2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2007,2009-2010]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	788	Tunisia	4	15	Northern Africa	Country	9.572737411	34.11439971	TUN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.34585	1.286039	0.216942	0.483399	3.524946	3.089307	1.986131	1.398053	1.202533	0.732094	3.624305	2.215238	0.78517	1.136888	1.906447	4.489971	0.128939	5.301602	5.301602			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	792	Turkey	4	145	Western Asia	Country	35.42890329	38.9899684	TUR	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.1732	0.414014	0.200888	0.140684	0.282999	0.262025	2.626706	6.52222	2.51705	1.47209	0.899083	0.937022	2.455377	3.10409	2.187829	2.301573	29.399513	166.132489	166.132489			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	795	Turkmenistan	4	143	Central Asia	Country	58.9787665	40.0912346	TKM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.905931	1.135889	1.938298	1.917649	1.511004	1.85608	1.949861	2.748777	1.437754	2.671499	5.943859	5.93523	2.313079	5.408573	4.420049	2.885028	10.232025	2.715396	2.715396			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	796	Turks and Caicos Islands	5	29	Caribbean	Country	-71.745121	21.80780585	TCA	0	1			[2004, 2005]	2004	2005	2	CON_USD	Constant USD	G	Global					0.091515	0.195379													0.195379			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	798	Tuvalu	4	61	Polynesia	Country	178.6679611	-7.460048071	TUV	1	1			[2001, 2002, 2003, 2005, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2001	2017	12	CON_USD	Constant USD	G	Global		5.727387	4.301452	1.592138		0.003117					0.179423	0.188508	0.094468	0.17486	0.107112	0.383313	0.677261	0.10094	0.10094			[2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2003,2005,2010-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	8	Albania	4	39	Southern Europe	Country	20.06660928	41.13897007	ALB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	9.375855	4.39696	5.817072	10.141369	6.922517	15.07856	9.53168	9.035682	5.975092	2.98343	4.709887	4.928938	2.980999	1.709264	2.041967	2.070803	1.887972	2.271278	2.271278			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	800	Uganda	5	14	Eastern Africa	Country	32.39100438	1.279557331	UGA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	50.485709	58.807865	28.267534	57.80351	57.539245	72.433148	84.280387	63.226271	80.071916	93.114622	93.275053	99.895526	206.996346	146.593985	191.051135	204.392133	265.346224	222.517757	222.517757			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	804	Ukraine	4	151	Eastern Europe	Country	31.40270802	49.00735945	UKR	1	1			[2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2005	2017	13	CON_USD	Constant USD	G	Global						8.256796	14.307495	11.348091	10.025726	7.834673	4.612268	18.345889	20.017279	20.788732	31.268428	51.995093	66.102068	34.015125	34.015125			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	807	North Macedonia	4	39	Southern Europe	Country	21.7007909	41.60048068	MKD	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.358548	8.04859	1.424528	0.646599	1.656225	0.136331	2.997711	1.521624	0.838647	0.997375	0.748246	2.675169	0.082652	1.897565	0.593172	1.40541	1.195577	1.027491	1.027491			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	818	Egypt	4	15	Northern Africa	Country	29.77468534	26.57438204	EGY	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	46.501697	29.95912	35.981914	10.967189	12.125707	21.477946	44.745652	63.448643	50.680562	18.281814	17.012482	12.787696	13.418037	6.047709	7.023683	13.569137	19.660251	4.481608	4.481608			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	834	United Republic of Tanzania	5	14	Eastern Africa	Country	34.80521182	-6.265332606	TZA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	21.762336	23.861792	29.644335	28.285504	57.566409	81.941466	98.082656	122.291385	172.172496	191.040547	217.93993	213.382379	250.597485	306.697953	277.028716	319.513251	0.959471	292.898417	292.898417			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	84	Belize	5	13	Central America	Country	-88.70199554	17.19965901	BLZ	1	1			[2000, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	17	CON_USD	Constant USD	G	Global	2.345332		0.150787	0.029845	0.00305	0.05078	0.051634	0.012695	0.007533	0.010388	0.808477	0.548685	0.492345	0.682086	1.202306	3.25593	3.163281	2.048066	2.048066			[2000]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	854	Burkina Faso	5	11	Western Africa	Country	-1.742843829	12.27491081	BFA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	5.332367	8.070722	8.791877	12.343644	27.351281	26.498603	34.237582	38.842431	49.927657	65.19699	96.817558	49.793489	76.017379	51.711748	78.066555	109.898518	173.913125	83.80867	83.80867			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	858	Uruguay	5	5	South America	Country	-56.01387025	-32.8002838	URY	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.051285	0.062877	0.358478	0.143105	0.390309	0.555317	0.318305	1.340735	0.268264	0.350321	2.807939	0.572131	0.622503	0.956294	0.285213	0.220989	0.156126	0.204819	0.204819			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	860	Uzbekistan	4	143	Central Asia	Country	63.11944558	41.77560518	UZB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	10.875623	9.249557	16.023316	10.249194	23.076905	15.685272	14.022967	14.70001	17.817438	20.688993	19.354127	18.412241	33.23643	25.09804	29.892154	22.854198	57.367997	39.830683	39.830683			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	862	Venezuela (Bolivarian Republic of)	5	5	South America	Country	-66.15642084	7.121324748	VEN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.584047	0.052722	0.0314	0.667831	0.302253	0.491288	0.296052	1.483065	1.278914	1.97089	0.884291	0.485613	0.324854	0.359593	0.275676	0.100466	0.080177	0.947556	0.947556			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	876	Wallis and Futuna Islands	4	61	Polynesia	Country	-176.2034788	-13.28471201	WLF	0	1			[2005, 2006, 2007, 2008, 2016, 2017]	2005	2017	6	CON_USD	Constant USD	G	Global						0.968367	0.947764	2.667823	0.412893								2.730117	0.61262	0.61262			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	882	Samoa	4	61	Polynesia	Country	-172.4430749	-13.61541469	WSM	1	1			[2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2002	2017	16	CON_USD	Constant USD	G	Global			0.224443	0.718795	0.288187	0.19894	0.087239	0.264816	0.866546	0.730479	4.319362	1.688427	2.353637	6.960288	0.938672	5.453046	1.494267	4.106414	4.106414			Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	887	Yemen	4	145	Western Asia	Country	45.22389143	15.22242099	YEM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	30.529754	2.738861	6.94921	10.776396	7.533302	20.413228	12.090355	22.799775	25.163113	19.658338	30.54421	32.411138	49.356877	81.654227	102.244354	67.931978	91.621994	285.007995	285.007995			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	894	Zambia	5	14	Eastern Africa	Country	27.850329	-14.59701056	ZMB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	33.129006	103.091864	37.520878	46.355394	62.442927	69.964767	61.968436	96.074757	88.260863	79.151796	46.366854	88.151639	121.056196	226.908462	65.813812	145.601936	181.009289	218.650807	218.650807			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	9	Oceania	2	1	World	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	132.969652	9.585761	82.204567	70.871774	54.418496	62.096907	34.045147	42.236343	62.938293	82.331961	50.656176	72.169971	68.42112	89.157065	46.237694	123.418461	61.429842	71.496892	71.496892			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	90	Solomon Islands	4	54	Melanesia	Country	160.1584117	-9.622391719	SLB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	7.084792	1.91376	0.324629	0.249841	0.797171	1.341441	0.149371	1.088526	16.493386	18.186563	9.168848	5.707938	5.017115	24.586918	4.833465	18.114319	16.615141	4.370048	4.370048			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q1.G.02	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2017 United States dollars)	921	ODA residual	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	282.122734	367.063616	578.760624	526.159092	682.002255	808.914132	866.972105	1563.066809	1206.060092	1449.224959	1517.239755	1339.109031	1301.437806	1655.909354	1593.256142	1825.51418	2254.857627	2323.784954	2323.784954			[2000-2001]: Commitments | Based on OECD, CRS databased, 2019 | Constant 2017 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million	OECD		C: Country data
